Inventor
RIVERA DANIEL S
US27 patents
⚠️ This page may combine multiple inventors who share the name “RIVERA DANIEL S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EPIVAX INC
15 patentsUS7884184B2Feb 8, 2011
Regulatory T cell epitopes, compositions and uses thereof
EPIVAX INC72 citations98
US10980867B2Apr 20, 2021
Regulatory T cell epitopes, compositions and uses thereof
EPIVAX INC3 citations84
US10925941B2Feb 23, 2021
Regulatory T cell epitopes, compositions and uses thereof
EPIVAX INC3 citations84
US10925939B2Feb 23, 2021
Regulatory T cell epitopes, compositions and uses thereof
EPIVAX INC3 citations84
US10925942B2Feb 23, 2021
Regulatory T cell epitopes, compositions and uses thereof
EPIVAX INC3 citations84
US10925940B2Feb 23, 2021
Regulatory T cell epitopes, compositions and uses thereof
EPIVAX INC3 citations84
US10751397B2Aug 25, 2020
Regulatory T cell epitopes, compositions and uses thereof
EPIVAX INC3 citations84
US10213496B2Feb 26, 2019
Regulatory T cell epitopes, compositions and uses thereof
EPIVAX INC3 citations84
US12016909B2Jun 25, 2024
Regulatory T cell epitopes, compositions and uses thereof
EPIVAX INC0 citations73
US11844826B2Dec 19, 2023
Regulatory T cell epitopes, compositions and uses thereof
EPIVAX INC0 citations73
US11045531B2Jun 29, 2021
Regulatory T cell epitopes, compositions and uses thereof
EPIVAX INC1 citations73
US11045530B2Jun 29, 2021
Regulatory T cell epitopes, compositions and uses thereof
EPIVAX INC1 citations73
US11045532B2Jun 29, 2021
Regulatory T cell epitopes, compositions and uses thereof
EPIVAX INC1 citations73
US11045529B2Jun 29, 2021
Regulatory T cell epitopes, compositions and uses thereof
EPIVAX INC1 citations73
US11045528B2Jun 29, 2021
Regulatory T cell epitopes, compositions and uses thereof
EPIVAX INC1 citations73
BIOVERATIV THERAPEUTICS INC
4 patentsUS9636416B2May 2, 2017
Immunoglobulin chimeric monomer-dimer hybrids
BIOVERATIV THERAPEUTICS INC20 citations91
US9725496B1Aug 8, 2017
Immunoglobulin chimeric monomer-dimer hybrids
BIOVERATIV THERAPEUTICS INC4 citations84
US11168125B2Nov 9, 2021
Immunoglobulin chimeric monomer-dimer hybrids
BIOVERATIV THERAPEUTICS INC1 citations73
US11401322B2Aug 2, 2022
Immunoglobulin chimeric monomer-dimer hybrids
BIOVERATIV THERAPEUTICS INC0 citations62
SYNTONIX PHARMACEUTICALS INC
3 patentsUS7862820B2Jan 4, 2011
Immunoglobulin chimeric monomer-dimer hybrids
SYNTONIX PHARMACEUTICALS INC120 citations98
US7404956B2Jul 29, 2008
Immunoglobulin chimeric monomer-dimer hybrids
SYNTONIX PHARMACEUTICALS INC301 citations98
US7348004B2Mar 25, 2008
Immunoglobulin chimeric monomer-dimer hybrids
SYNTONIX PHARMACEUTICALS INC218 citations98